Health Trials

Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical Practice

ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorDuk-Woo Park, MD

About this trial

This study is to evaluate the effectiveness and safety of Ultimaster Tansei stent and/or Ultimaster Nagomi stent in the "real-world" daily practice.

Eligibility criteria

Qualifiers

Patients ≥ 19 years old

Patients receiving Ultimaster™ Tansei™ stent and/or Ultimaster Nagomi™ stents.

The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Disqualifiers

Patients with a mixture of other drug-eluting stents (DESs)

Terminal illness with life-expectancy ≤1 year.

Patients with cardiogenic shock

Trial design

Treatments tested in this trial

  • Ultimaster™ Tansei™ stent and/or Ultimaster Nagomi™ stent

Treatment groups

2,000 Participants
are divided into 1 treatment group

Locations

11
Gangwon National Univ. Hospital Chuncheon South Korea
Daegu Catholic University Medical Center Daegu South Korea
Keimyung University Dongsan Medical Center Daegu South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon South Korea

Sponsors and collaborators

Duk-Woo Park, MD

Lead sponsor

Asan Medical Center

Sponsor institution

CardioVascular Research Foundation, Korea

Collaborator

Source ClinicalTrials.gov